European Journal of Neurology

Article	Citations
	203
Issue Information	137
Structural correlations between brain magnetic resonance image‐derived phenotypes and retinal neuroanatomy	116
Lessons from the past to understand the future	113
Advancements in targeted therapies for generalized acetylcholine receptor antibody positive myasthenia gravis: Beginnings of a paradigm shift	96
Concerns Regarding “Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy”	95
Cost‐effectiveness of acceptance and commitment therapy for people living with motor neuron disease, and their health‐related quality of life	82
Long‐Term Improvements Following Initial Migraine Response in Eptinezumab‐Treated Participants With Migraine for Whom 2–4 Prior Preventive Treatments Have Failed	81
	79
	71
Response to erenumab assessed by Headache Impact Test‐6 is modulated by genetic factors and arterial hypertension: An explorative cohort study	71
Progressive multifocal leukoencephalopathy in a patient with relapsing multiple sclerosis treated with ocrelizumab: A case report	68
Electroencephalography functional connectivity—A biomarker for painful polyneuropathy	68
Contribution of Polygenic Scores to Progression Independent of Relapse Activity in Multiple Sclerosis	67
Neurovascular Involvement in Fibromuscular Dysplasia: A Clue for Reappraisal of Old Classifications	64
Comparative features and outcomes of major neurological complications of COVID‐19	60
Prioritization process for European Academy of Neurology clinical practice guidelines	60
Hearing impairment and development of parkinsonism and possible rapid eye movement sleep behaviour disorder: A CLSA prospective population‐based study	59
The effect of influenza vaccination on the rate of dementia amongst older adults	58
Markers of Giant Cell Arteritis in Patients Presenting With Ischemic Stroke: A Scoping Review	55
Prevalence and Impact of Probable REM Sleep Behavior Disorder in Essential Tremor: A Multicenter Cross‐Sectional Study	54
Basal ganglia ischaemic infarction after thrombectomy: cognitive impairment at acute stage	52
Ischaemic cerebral small vessel disease caused by adenosine deaminase 2 deficiency syndrome	49
Clusters of Comorbidities in Multiple Sclerosis and Their Influence on Healthcare Resource Usage	48
CCR5‐Δ32polymorphism—a possible protective factor from gait impairment amongst post‐stroke patients	48

Levodopa–entacapone–carbidopa intestinal gel: Data from the Swedish national registry for Parkinson's disease	47
The microbiome–gut–brain axis in epilepsy: pharmacotherapeutic target from bench evidence for potential bedside applications	45
Issue Information	45
Diagnostic accuracy of nerve excitability and compound muscle action potential scan derived biomarkers in amyotrophic lateral sclerosis	44
Effect of efgartigimod on muscle group subdomains in participants with generalized myasthenia gravis: post hoc analyses of the phase 3 pivotal ADAPT study	44
The 2022 European postgraduate (residency) programme in neurology in a historical and international perspective	44
Erenumab and OnabotulinumtoxinA in Chronic Migraine: A Comparative Analysis	43
Switching from ligand to receptor anti‐calcitonin gene‐related peptide (CGRP) antibodies or vice versa in non‐responders: A controlled cohort study	43
Defining Activity‐Based Subgroups in Multiple Sclerosis: A Review and Framework Proposal	43
A multicenter, randomized, open‐label, phase 2 clinical study of telitacicept in adult patients with generalized myasthenia gravis	43
Quantitative Neuromuscular MRI in CIDP Patients: Interest of a Multiparametric Approach	42
Correlation between patient‐reported manual ability and three objective measures of upper limb function in people with multiple sclerosis	41
Inclusive Language for Inclusive Care—A Proposal for an LGBTQI + Glossary for European Neurologists	41
Central nervous system crystal‐storing histiocytosis: A case report and literature review	41
Mindfulness or meditation therapy for Parkinson's disease: A systematic review and meta‐analysis of randomized controlled trials	40
Neuropsychological Tests for Detecting Prodromal DLB : A Systematic Review	39
Neurological phenotype of adenosine deaminase 2 deficient patients: a cohort study	39
Clinical and Genetic Reassessment in Patients With Clinically Diagnosed Hereditary Polyneuropathy	38
1‐Year Clinical Outcome Post‐Myasthenic Crisis: A Multicenter Prospective Study in China	38
ePoster	38
Risdiplam in types 2 and 3 spinal muscular atrophy: A randomised, placebo‐controlled, dose‐finding trial followed by 24 months of treatment	38
Issue Information	37
Neuropathy in GAA‐FGF14 Late‐Onset Cerebellar Ataxia (SCA27B): Prevalence and Characteristics	37
	37
Predictors of Multiple Sclerosis After Clinically Isolated Syndrome: A Systematic Review and Meta‐Analysis	37
Peripheral neuropathy in ataxia‐telangiectasia: Newly characterized, has potential as a biomarker	36
Nonamyloidogenic TTR gene variants c.76G>A and c.337‐18G>C are not associated with idiopathic small‐fiber neuropathy	36
SARS‐CoV‐2 cannot unmask Parkinson's disease if there was none before infection	36
A clinical concern: Neisseria meningitidis as a reemerging pathogen with increased antimicrobial resistance	36
Nerve Conduction Study and the Prognosis of Amyotrophic Lateral Sclerosis: Exploration of Additional Neuroelectrophysiological Parameters	35
Issue Information	35
Trajectories of physical activity after ischaemic stroke: Exploring prediction of change	34
A Transfer Strategy Utilizing a Helicopter and a Ground Ambulance Together Does Not Prolong Door‐In‐Door‐Out Times in Thrombectomy Patients: A Retrospective Analysis	34
Myoclonus in patients with COVID‐19: Findings of autoantibodies against brain structures in cerebrospinal fluid	34
Lower initial red blood cell count in cerebrospinal fluid predicts good functional outcome in patients with spontaneous subarachnoid haemorrhage	33
Apolipoprotein E epsilon4 allele is associated with better performance language and visual memory in spinocerebellar ataxia type 3	33
A Novel 3D Semi‐Automated Full Quantification Technique for Detection of Intraneural Phospho‐α‐Synuclein in Skin Biopsies	33
Alterations of Fat and Ketone Body Metabolism in ALS and SMA—A Prospective Observational Study	33
Dehydration associates with lower urinary tract symptoms in progressive multiple sclerosis	33
Intraepineurial Fat Fraction: A Novel MR Neurography‐Based Biomarker in Transthyretin Amyloidosis Polyneuropathy	33
Antipsychotics and Their Association With Long‐Term Outcomes in Young Ischemic Stroke Patients	33
Contractile properties and magnetic resonance imaging‐assessed fat replacement of muscles in myotonia congenita	32
Issue Information	31
Oral Presentations	31
Type 2 diabetes mellitus duration and subsequent risk of Alzheimer disease	30
Prevalence and Spectrum of Neuropathies in a Cohort of 585 Patients With Immunoglobulin A Monoclonal Gammopathy	30
Renal Cell Carcinoma With Unknown Primary in the Femur: The Loch Ness Monster?	29
Abnormal Sleep in Chronic Inflammatory Demyelinating Polyneuropathy	29
Arterial Stiffness, Central Blood Pressure, and the Risk of Incident Stroke in Hypertensive Adults	29
Treatment reduces the incidence of newly appearing multiple sclerosis lesions evolving into chronic active, slowly expanding lesions: A retrospective analysis	28

Risk of New‐Onset Myasthenia Gravis Following COVID ‐19 Infection and Vaccination: A Population‐Based Case–Control Study	28
Letter to the Editor: “Headache After Sealing of Cerebrospinal Fluid Leaks in Patients With Spontaneous Intracranial Hypotension”	28
Corrigendum to “Tremor After Solid Organ Transplantation: Results From the TransplantLines Biobank and Cohort Study”	28
Exploring the role of attention towards balance in chronic dizziness: Development of the Balance Vigilance Questionnaire	27
High‐resolution magnetic resonance imaging of acute intracranial artery thrombus	27
‘Positive’ inter‐ictal clinical signs of functional neurological disorders are found in patients with functional dissociative seizures	27
Generative artificial intelligence in neurology: Opportunities and risks	27
Hypersomnia in anti‐glutamic acid decarboxylase 65 (GAD65) associated neurological syndromes: A pilot study	27
Etiologic distribution of isolated abducens nerve palsy: Analysis of 807 patients and literature review	27
Hyperreflective retinal foci are associated with retinal degeneration after optic neuritis in neuromyelitis optica spectrum disorders and multiple sclerosis	27
Hereditary Transthyretin Amyloidosis in Israel: Genetic Landscape and Clinical Characteristics	27
Clinically relevant increases in serum neurofilament light chain and glial fibrillary acidic protein in patients with Susac syndrome	27
IgG4‐Related Disease Associated With Myotonic Dystrophy Type 2	27
Effectiveness and safety of levodopa–entacapone–carbidopa infusion in Parkinson disease: A real‐world data study	27
Hyponatremia is associated with unfavorable outcomes after reperfusion treatment in acute ischemic stroke	27
Education for fatigue management in people with multiple sclerosis: Systematic review and meta‐analysis	26
Intestinal histomorphological and molecular alterations in patients with Parkinson's disease	26
Neurology Undergraduate Medical Education: A Scoping Review	26
Epilepsy professionals' views on sudden unexpected death in epilepsy counselling: A tale of two countries	26
Causes of hospitalization and mortality in persons with epilepsy: The EpiLink Bologna cohort, Italy	26
Can Non‐Thymomatous Late‐Onset Myasthenia Gravis Benefit From Thymectomy? A Systematic Review and Meta‐Analysis	25
Risk of Parkinson disease in stroke patients: A nationwide cohort study in South Korea	25
A diagnostic framework to identify vestibular involvement in multi‐sensory neurological disease	25
Diverging medical and legal perceptions of the need for legal guardianship in people with dementia: A qualitative study	25
Optic Nerve Lesion Volume, White Matter Hyperintensities, and Brain Volumetrics in Multiple Sclerosis: A Multi‐Sequence MRI ‐Based Analysis	25
Symposia	25
Cluster headache polygenetic risk and known functional variants of CYP3A4 are not associated with treatment response	25
Elevated Serum MCP‐2 and TARC Associated With Increased Risk of Death in Guamanian ALS Patients	25
Development of Machine‐Learning‐Based Models for Detection of Cognitive Impairment in Patients Receiving Maintenance Hemodialysis	24
Predominant right temporal lobe atrophy: Clinical, neuropsychological and structural differences based on amyloid status	24
Quantification of muscle involvement in familial amyloid polyneuropathy using MRI	24
Meningoencephalitis due to Mycobacterium lentiflavum in an immunocompromised patient: Case report	24
Issue Information	24
Switching from natalizumab to antiCD20 monoclonal antibodies: Short transition interval is associated with improved outcome	24
Key priorities in rare neurological diseases: A statement from the Coordinating Panel on Rare Neurological Diseases of the European Academy of Neurology	24
Longitudinal analysis of anthropometric measures over 5 years in patients with Friedreich ataxia in the EFACTS natural history study	24
	24
Comment on “Association between depression and motoric cognitive risk syndrome among community‐dwelling older adults in China: A 4‐year prospective cohort study”	23
Optimal cut‐off value of the modified Toronto Clinical Neuropathy Score in the diagnosis of polyneuropathy	23
Plenary Sessions	23
Staging Language‐Led Neurodegenerative Diseases in a Language‐Based World: The Challenge of the PPA ‐Squared Scale	23
Clinical and Genetic Characterization of the Largest Cohort of Patients With D3 Limb‐Girdle Muscular Dystrophy in an Isolated Uruguayan Population	23
Comparison between PFN1 and SOD1 mutations in amyotrophic lateral sclerosis	23
Smartphone and custom‐made software to assess the effect of botulinum toxin in essential blepharospasm: Initial results	23
ePresentations	23
HAPLN3 p.T34A contributes to incomplete penetrance of moyamoya disease in Chinese carrying RNF213 p.R4810K	22
A fast and non‐invasive artificial intelligence olfactory‐like system that aids diagnosis of Parkinson's disease	22
Retrograde Amnesia in LGI1 and CASPR2 Limbic Encephalitis: Two Case Reports and a Systematic Literature Review	22
Quantitative proteomic analysis of cerebrospinal fluid from patients with idiopathic facial nerve palsy	22
Combined Brain‐Cardiac CT in Ischemic Stroke: Unveiling Atrial Markers Linked to Large Vessel Occlusion in AF Patients	22
Glutamine Metabolism and Metabolic Profiling Using 7 T CRT‐FID MRSI in Focal Epilepsy	22
New cellular imaging‐based method to distinguish the SPG4 subtype of hereditary spastic paraplegia	22
Spinal muscular atrophy: Should we prescribe approved drugs to cohorts of patients in which they are unproven?	22
Serum neurofilament light chain does not detect self‐reported treatment‐related fluctuations in chronic inflammatory demyelinating polyneuropathy	22
Responder rates with eptinezumab over 24 weeks in patients with prior preventive migraine treatment failures: post hoc analysis of the DELIVER randomized clinical trial	22
Association between COVID‐19 vaccination and myasthenia gravis: A population‐based, nested case–control study	21
Spontaneous intracranial hypotension — Neurological symptoms, diagnosis, and outcome	21
Cerebrotendinous xanthomatosis: A complex interplay between a clinically and genetically heterogeneous condition	21
Prospective follow‐up study of youth and adults with onset of functional tic‐like behaviours during the COVID‐19 pandemic	21
Association of APOE genotype and cerebrospinal fluid Aβ and tau biomarkers with cognitive and motor phenotype in amyotrophic lateral sclerosis	21
Histopathological characterization of cerebral small vessel disease in epilepsy patients with temporal lobe epilepsy submitted to surgery: A case–control study	21
Structural Alterations Associated With Cardiovascular Autonomic Failure in Multiple System Atrophy	21
Therapeutic choices and disease activity after 2 years of treatment with cladribine: An Italian multicenter study (CladStop)	21
Rubella virus seropositivity after infection or vaccination as a risk factor for multiple sclerosis	21
The many faces of globular glial tauopathy: A clinical and imaging study	20
Brain Iron Alteration in Pediatric Tourette Syndrome: A Quantitative Susceptibility Mapping Study	20
Association of aberrant brain network dynamics with gut microbial composition uncovers disrupted brain–gut–microbiome interactions in irritable bowel syndrome: Preliminary findings	20
Exercise induced muscle blood flow is decreased in Charcot–Marie–Tooth disease type 1 polyneuropathy: a power Doppler analysis	20
Prolonged venous transit is associated with lower odds of excellent recovery after reperfusion in anterior large‐vessel occlusion stroke	20
Post‐ COVID ‐Syndrome Patients Might Overestimate Own Cognitive Impairment	20
Parkinson´s disease cardiovascular symptoms: A new complex functional and structural insight	20
Epilepsy Management in Transgender Population: More Research for Better Treatment	20
Tracking myasthenia gravis severity over time: Insights from the French health insurance claims database	20
Mutations in alpha‐B‐crystallin cause autosomal dominant axonal Charcot–Marie–Tooth disease with congenital cataracts	19
Prognostic impact of intracranial arteriosclerosis subtype after endovascular treatment for acute ischaemic stroke	19
Data‐Driven Clustering Approach to Identify Different Phenotypes of Primary Central Nervous System Vasculitis	19
Cardioembolic Breakthrough Stroke: When Anticoagulation Fails, Is Left Atrial Appendage Closure the Next Step?	19
Socioeconomic status as a risk factor for motoric cognitive risk syndrome in a community‐dwelling population: A longitudinal observational study	19
Refocusing generalized myasthenia gravis: Patient burden, disease profiles, and the role of evolving therapy	19
A Real‐World Study of CGRP Monoclonal Antibodies for Migraine: Long‐Term Effectiveness and Treatment Adherence	19

Comparative Analysis of SiMoA and Ella Immunoassay Platforms for Measuring Serum Neurofilament Light Chain Levels in ATTRv With Polyneuropathy and Presymptomatic Carriers	19
Focused Workshop	19
Machine Learning for Diagnosis and Differentiation of Central Disorders of Hypersomnolence: A Systematic Review	19
Association between choroid plexus volume and cognition in Parkinson disease	19
Serum neurofilament light chain and glial fibrillary acidic protein for predicting response to apheresis in steroid‐refractory multiple sclerosis relapses	19
Clinical presentation and neural correlates of stroke‐associated spatial delusions	19
Long‐term follow‐up of 64 children with classical infantile‐onset Pompe disease since 2004: A French real‐life observational study	18
Distinctive Progression Patterns of Brain Structural Damage Aid Classification of Frontotemporal Dementia Variants	18
Optimizing Prehospital Acute Transfer of Patients With Presumed Stroke Given Economic Constraints	18
History of Traumatic Brain Injury Does Not Influence Rate of Progression of Clinical or Pathological Outcomes in Two Early Parkinson's Disease Cohorts	18
Diagnostic Yield of Anti‐Neuronal Antibody Testing in Patients Suspected of an Infectious Encephalitis	18
Quantitative Brain MRI Analysis in Neurodegenerative Langerhans Cell Histiocytosis	18
Autoimmune encephalitis: Should we consider third‐line immunotherapies earlier?	18
Special Sessions	18
Global Temporal Trends and Projections of Stroke Among Women of Childbearing Age: An Age–Period–Cohort Analysis Based on the Global Burden of Disease Study 2021	18
The spectrum of central nervous system involvement in Whipple's disease	18
Neurofilament light chain and profilin‐1 dynamics in 30 spinal muscular atrophy type 3 patients treated with nusinersen	18
Diagnostic accuracy of nerve ultrasonography for the detection of peripheral neuropathy in type 2 diabetes	18
Giancarlo COMI (1947–2024)	18
Issue Information	18
Decrement of choroid vascularization during spontaneous migraine attacks: An optical coherence tomography angiography study	17
Glymphatic Function in Prodromal Parkinson's Disease: Associations With Symptoms, Gray Matter Volume, and Phenoconversion Risk	17
The effect of head‐down tilt in experimental acute ischemic stroke	17
Safety and Effectiveness of PCSK9 Inhibitors and Inclisiran in Patients With Neuromuscular Disorders and Statin Intolerance	17
Cerebral Amyloid Angiopathy‐Related Inflammation in Iatrogenic Cerebral Amyloid Angiopathy	17
Sex differences in early‐onset Alzheimer's disease	17
Expert opinions on pharmacological symptomatic treatment of behavioral symptoms in frontotemporal dementia: A survey of the Neuropsychiatric International Consortium on Frontotemporal Dementia (NIC‐FT	17
Symposia	17
Cost‐effectiveness of surgical treatment compared to medical treatment in patients with drug‐refractory epilepsy: A systematic review	17
Midline sacral meningeal cysts: Neurophysiology abnormalities and their correlation with pelvic sensory and visceral symptoms	17
Cannabis and Cognitive Function in Multiple Sclerosis: Findings From a Large Consecutive Clinical Sample	17
Central vein sign and paramagnetic rim sign: From radiologically isolated syndrome to multiple sclerosis	17
Plenary Symposium	17
Aetiology of Acute Respiratory Insufficiency in Patients With Ischaemic Stroke Studied by Chest CT Scan	17
Long‐Term Outcomes in Stiff Person Spectrum Disorder	17
The impact of hybrid immunity on immune responses after SARS‐CoV‐2 vaccination in persons with multiple sclerosis treated with disease‐modifying therapies	17
Functional outcome after initial and multiple intracerebral hemorrhages in children with cerebral cavernous malformations	17
Oral Presentation	16
Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report	16
Unraveling brain fog in post‐COVID syndrome: Relationship between subjective cognitive complaints and cognitive function, fatigue, and neuropsychiatric symptoms	16
Relationship between migraine and epilepsy in a large population‐based cohort: The HUNT Study	16
Sex and Gender Differences in the Association Between Physical Activity and Cryptogenic Ischemic Stroke in Young Adults	16
	16
Three to four mRNA COVID‐19 vaccines in multiple sclerosis patients on immunosuppressive drugs: Seroconversion and variant neutralization	16
Parkinson disease following COVID‐19: Report of six cases	16
Global Health Inequalities in the Burden of Ischemic Stroke From 1990 to 2021	16
Analysis of individual alpha frequency in a large cohort from a tertiary memory center	16
Concurrent Sporadic Late‐Onset Nemaline Myopathy and an Excessive Glycogen Accumulation Associated With Monoclonal Gammopathy	16
High serum neurofilament light chain levels correlate with brain atrophy and physical disability in multiple sclerosis	16
Compassionate mind training for people with Parkinson's disease: A pilot study and predictors of response	16
Magnetic resonance imaging Locus Coeruleus abnormality in amnestic Mild Cognitive Impairment is associated with future progression to dementia	16
Peripherin: A Novel Early Diagnostic and Prognostic Plasmatic Biomarker in Amyotrophic Lateral Sclerosis	16
Clinical autonomic nervous system laboratories in Europe	16
Nonstenotic intracranial atherosclerosis as an emerging mechanism in cryptogenic cerebral embolism	15
Breast Cancer Screening in Women With Multiple Sclerosis: A Mixed‐Methods Study	15
Nerve Conduction Abnormalities Beyond Conduction Block in Multifocal Motor Neuropathy. Impact on Diagnostic Criteria Accuracy	15
Central nervous system cavernous malformations: cross‐sectional study assessing rebleeding risk after a second haemorrhage	15
Globus pallidus internus versus subthalamic nucleus deep brain stimulation for isolated dystonia: A 3‐year follow‐up	15
Small Fiber Morphology and Function in Inclusion Body Myositis—A Multimodal Assessment Including Confocal Corneal Microscopy	15
Thank You to Our Peer Reviewers in 2024	15
Clinical outcomes of delayed mechanical thrombectomy: Descriptive analysis and development of a screening tool	15
Association of diabetes mellitus with dementia‐ and non‐dementia‐related mortality amongst women: a secondary competing risks analysis of the California Teachers Study	15
Correction to “Tirofiban Benefits the Outcome of Stroke Patients With Large Artery Atherosclerosis Achieving Full Reperfusion and High NIHSS Scores”	15
The rise and fall of Queckenstedt's test between 1916 and 1970, a milestone in spinal cord diagnostics and why it matters	15
Atrial fibrillation in young stroke patients: Associated factors and outcomes in a nationwide analysis	15
	15
Focused Workshops	15
	15
Shoulder‐Touch test to reveal incongruencies in persons with functional motor disorders	15
SerpinA1 levels in amyotrophic lateral sclerosis patients: An exploratory study	15
Olfactory Dysfunction and/or RBD for Mapping Parkinson's Disease Subtypes?	15
Migraine worsening after COVID‐19 and COVID‐19 vaccination: Are we facing a nocebo effect?	14
Severity‐Dependent Neuroaxonal Damage Assessed by Serum Neurofilaments in ICANS Patients Undergoing CD19‐Targeted CAR T‐Cell Therapy	14
A founder variant in the RYR1 gene is associated with hyperCKemia, myalgia and muscle cramps	14
The first European Academy of Neurology (EAN) Science School: shaping the next generation of translational neurologists	14
Association Between Migraine and Periodontitis: A Systematic Review and Meta‐Analysis	14
Joint Modelling of Growth and Motor Function Centiles in Corticosteroids Treated Boys With Duchenne Muscular Dystrophy	14
Plasma neuropeptide Y levels and adverse clinical outcomes after acute ischaemic stroke	14
Issue Information	14
A comparative study of hypothalamic involvement in patients with myelin oligodendrocyte glycoprotein antibody‐associated disease, neuromyelitis optica spectrum disorder, and multiple sclerosis	14
White matter hyperintensities in cognitive impairment with Lewy body disease: a multicentre study	14
GGC expansions in NOTCH2NLC contribute to Parkinson disease and dopaminergic neuron degeneration	14
Plasma homeostatic chemokines CCL19 and CCL21 and the prognosis of ischemic stroke in two Chinese prospective cohorts	14
Comment on “Variation in Repeated Handgrip Strength Testing Indicates Submaximal Force Production in Patients With Myalgic Encephalomyelitis/Chronic Fatigue Syndrome”	14
The 20th anniversary of the first clinical use of Stalevo®	14
Migraine Patients Treated With Erenumab and the Risk of Hypertension: A Registry‐Based Real‐World Study	14
Misfolded alpha‐synuclein in amyotrophic lateral sclerosis: Implications for diagnosis and treatment	14
	14
Clinical Findings in Temporal Lobe Epilepsy Associated With Isolated Amygdala Enlargement	14
Neurological autoimmunity in patients with non‐pulmonary neuroendocrine neoplasms: clinical manifestations and neural autoantibody profiles	14
Pain in Functional Motor Disorders: Clinical Correlates From the Italian Registry	14
Catechol‐O‐methyltransferase inhibition with entacapone: Evidence from controlled clinical trials in Parkinson's disease	14
Greek Registry for Amyotrophic Lateral Sclerosis (ALS‐GR): An Observational Cohort of Individuals With ALS Across 11 Specialized Centers in Greece	14
Long‐Term Effectiveness of Early Versus Late Microvascular Decompression for Trigeminal Neuralgia Secondary to Arterial Compression	14
Long‐term prognosis of fatty‐acid oxidation disorders in adults: Optimism despite the limited effective therapies available	14